CIK 0001674632 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Beta Bionics, Inc.
Sign in to watch- Ticker
- BBNX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475386878
- Phone
- 949-427-7785
- Business address
- 11 HUGHES, IRVINE, CA, 92618
- Former names
- Beta Bionics, Inc
- 4 Open-market sale Chief Commercial Officer sold 868 shares at an average $17.89 ($15,529)
- 4 Open-market sale Chief Medical Officer sold 1,039 shares at an average $17.89 ($18,588)
- 4 Open-market sale Chief Product Officer sold 1,115 shares at an average $17.89 ($19,948)
- 4 Open-market sale Chief Financial Officer sold 1,497 shares at an average $17.89 ($26,783)
- 4 Open-market sale President & CEO sold 3,439 shares at an average $17.89 ($61,526)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-K/A Report 10-K/A
- 4 Grant or award Director acquired 12,547 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Grant or award Director acquired 11,247 shares (grant or award)
Page 10 of 15 · 290 filings